Abrocitinib reverses the altered immune and skin barrier phenotype in skin biopsies from patients with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Del Duca, E. [1 ]
Guttmann-Yassky, E. [1 ]
Da Rosa, Jc [1 ]
Estrada, Y. [1 ]
Kim, M. [1 ]
Facheris, P. [2 ]
Gomez-Arias, Pj [3 ]
Page, K. [4 ]
Guller, E. [5 ]
Xu, D. [6 ]
Chen, A. [7 ]
Chan, G. [7 ]
Kerkmann, U. [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] IRCCS Humanitas Res Hosp, Rozzano, Italy
[3] Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain
[4] Pfizer Inc, Cambridge, MA USA
[5] Pfizer Inc, Istanbul, Turkiye
[6] Pfizer Inc, San Diego, CA USA
[7] Pfizer Inc, Groton, CT USA
[8] Pfizer Pharma GmbH, Berlin, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
204
引用
收藏
页码：S366 / S366
页数：1
相关论文
共 50 条
  • [41] Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
    Zhou, Lisa
    Leonard, Alexandra
    Pavel, Ana B.
    Malik, Kunal
    Raja, Aishwarya
    Glickman, Jacob
    Estrada, Yeriel D.
    Peng, Xiangyu
    del Duca, Ester
    Sanz-Cabanillas, Juan
    Ruano, Juan
    Xu, Hui
    Zhang, Ning
    Wen, Huei-Chi
    Gonzalez, Juana
    Garcet, Sandra
    Krueger, James G.
    Guttman-Yassky, Emma
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (01) : 144 - 156
  • [42] Symptom burden of patients with moderate-to-severe atopic dermatitis
    Egeberg, Alexander
    Anderson, Peter
    Piercy, James
    Massey, Lucy
    Cappelleri, Joseph C.
    Encinas, Gerardo A.
    Feeney, Claire
    Dibonaventura, Marco
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (06) : 752 - 758
  • [43] Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis
    Yang, Gabsik
    Seok, Jin Kyung
    Kang, Han Chang
    Cho, Yong-Yeon
    Lee, Hye Suk
    Lee, Joo Young
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [44] Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    de Bruin-Weller, Marjolein
    Calimlim, Brian M.
    Hu, Xiaofei
    Ofori, Sarah A.
    Platt, Andrew M.
    Teixeira, Henrique D.
    Eyerich, Kilian
    Thyssen, Jacob P.
    [J]. DERMATITIS, 2024, 35 (03) : 266 - 274
  • [45] Safety of abrocitinib in 3582 patients with moderate-to-severe atopic dermatitis with over 900 patients exposed for almost 2 years
    Simpson, Eric L.
    Silverberg, Jonathan, I
    Nosbaum, Audrey
    Winthrop, Kevin
    Guttman-Yassky, Emma
    Hoffmeister, Karin M.
    Egeberg, Alexander
    Valdez, Hernan
    Fan, Haiyun
    Farooqui, Saleem A.
    Chan, Gary
    Alderfer, Justine
    Romero, William
    Johnson, Susan
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [46] Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis
    Hartmann, Jan
    Moitinho-Silva, Lucas
    Sander, Nicole
    Harder, Inken
    Haesler, Robert
    Rodriguez, Elke
    Haufe, Eva
    Kleinheinz, Andreas
    Abraham, Susanne
    Heratizadeh, Annice
    Weisshaar, Elke
    Schaekel, Knut
    Handrick, Christiane
    Augustin, Matthias
    Wollenberg, Andreas
    Staubach-Renz, Petra
    Ertner, Konstantin
    Sticherling, Michael
    Schwarz, Beate
    Quist, Sven
    Wiemers, Franca
    Schenck, Florian
    Wildberger, Julia
    Tittmann, Lukas
    Lieb, Wolfgang
    Schmitt, Jochen
    Werfel, Thomas
    Weidinger, Stephan
    [J]. ALLERGY, 2023, 78 (08) : 2290 - 2300
  • [47] Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis
    Mocsai, G.
    Gaspar, K.
    Nagy, G.
    Irinyi, B.
    Kapitany, A.
    Biro, T.
    Gyimesi, E.
    Toth, B.
    Marodi, L.
    Szegedi, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (03) : 617 - 624
  • [48] Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
    Li, Ling
    Yu, Jiajun
    Chen, Baoqing
    Guo, Ying
    Yang, Yufeng
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] Integrated safety analysis of abrocitinib in 3802 patients with moderate-to-severe atopic dermatitis with over 5000 patientyears of exposure
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Nosbaum, Audrey
    Winthrop, Kevin
    Guttman-Yassky, Emma
    Egeberg, Alexander
    Fan, Haiyun
    Alderfer, Justine
    Johnson, Susan
    Farooqui, Saleem
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (01)
  • [50] Dupilumab treatment restores skin barrier function measured by transepidermal water loss in adults and adolescents with moderate-to-severe atopic dermatitis
    Bissonnette, R.
    Ramirez-Gama, M.
    Garcia, S.
    Taylor, P.
    Praestgaard, A.
    Levit, N. A.
    Rossi, A. B.
    Zhang, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E156 - E156
12345